[ad_1] Newswise – While COVID-19 infected patients should be treated with standard anticoagulant therapies, such as blood-thinning medications, a new study by George Washington University (GW) researchers shows that anticoagulant patients at higher doses, without the traditional medical indications for doing so can be ineffective and even harmful. The study …
Read More »The benefits of high-dose anticoagulants in COVID-19 patients remain unclear
